Global Gastrointestinal Therapeutics Market Professional Survey Report 2017

Publisher Name :
Date: 22-Jan-2018
No. of pages: 120
Inquire Before Buying

This report studies Gastrointestinal Therapeutics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

- Johnson & Johnson

- AbbVie

- Allergan

- Takeda

- Novartis

- Pfizer

- GlaxoSmithKline

- Merck

- UCB (Belgium)

- F. Hoffmann-La Roche

- Eli Lilly

- AstraZeneca

- Procter & Gamble

- Eisai

- Shire Pharmaceuticals

- Ferring Pharmaceuticals

- Kyowa Hakko Kirin

- Salix Pharmaceuticals

- Ono Pharmaceutical

- TSD Japan

- RedHill Biopharma

- Kaken Pharmaceutical

- Amgen

- Synergy Pharmaceuticals

- Ajinomoto

- Kissei Pharmaceutical

- Hutchison Medi Pharma

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Tablets

- Injection

By Application, the market can be split into

- IBD

- Irritable Bowel Syndrome (IBS)

- Other

By Regions, this report covers (we can add the regions/countries as you want)

- North America

- China

- Europe

- Southeast Asia

- Japan

- India

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Gastrointestinal Therapeutics Market Professional Survey Report 2017

Table of Contents
Global Gastrointestinal Therapeutics Market Professional Survey Report 2017
1 Industry Overview of Gastrointestinal Therapeutics
1.1 Definition and Specifications of Gastrointestinal Therapeutics
1.1.1 Definition of Gastrointestinal Therapeutics
1.1.2 Specifications of Gastrointestinal Therapeutics
1.2 Classification of Gastrointestinal Therapeutics
1.2.1 Tablets
1.2.2 Injection
1.3 Applications of Gastrointestinal Therapeutics
1.3.1 IBD
1.3.2 Irritable Bowel Syndrome (IBS)
1.3.3 Other
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 Manufacturing Cost Structure Analysis of Gastrointestinal Therapeutics
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Gastrointestinal Therapeutics
2.3 Manufacturing Process Analysis of Gastrointestinal Therapeutics
2.4 Industry Chain Structure of Gastrointestinal Therapeutics
3 Technical Data and Manufacturing Plants Analysis of Gastrointestinal Therapeutics
3.1 Capacity and Commercial Production Date of Global Gastrointestinal Therapeutics Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Gastrointestinal Therapeutics Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Gastrointestinal Therapeutics Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Gastrointestinal Therapeutics Major Manufacturers in 2016
4 Global Gastrointestinal Therapeutics Overall Market Overview
4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2012-2017E Global Gastrointestinal Therapeutics Capacity and Growth Rate Analysis
4.2.2 2016 Gastrointestinal Therapeutics Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2012-2017E Global Gastrointestinal Therapeutics Sales and Growth Rate Analysis
4.3.2 2016 Gastrointestinal Therapeutics Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2012-2017E Global Gastrointestinal Therapeutics Sales Price
4.4.2 2016 Gastrointestinal Therapeutics Sales Price Analysis (Company Segment)
5 Gastrointestinal Therapeutics Regional Market Analysis
5.1 North America Gastrointestinal Therapeutics Market Analysis
5.1.1 North America Gastrointestinal Therapeutics Market Overview
5.1.2 North America 2012-2017E Gastrointestinal Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2012-2017E Gastrointestinal Therapeutics Sales Price Analysis
5.1.4 North America 2016 Gastrointestinal Therapeutics Market Share Analysis
5.2 China Gastrointestinal Therapeutics Market Analysis
5.2.1 China Gastrointestinal Therapeutics Market Overview
5.2.2 China 2012-2017E Gastrointestinal Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2012-2017E Gastrointestinal Therapeutics Sales Price Analysis
5.2.4 China 2016 Gastrointestinal Therapeutics Market Share Analysis
5.3 Europe Gastrointestinal Therapeutics Market Analysis
5.3.1 Europe Gastrointestinal Therapeutics Market Overview
5.3.2 Europe 2012-2017E Gastrointestinal Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2012-2017E Gastrointestinal Therapeutics Sales Price Analysis
5.3.4 Europe 2016 Gastrointestinal Therapeutics Market Share Analysis
5.4 Southeast Asia Gastrointestinal Therapeutics Market Analysis
5.4.1 Southeast Asia Gastrointestinal Therapeutics Market Overview
5.4.2 Southeast Asia 2012-2017E Gastrointestinal Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2012-2017E Gastrointestinal Therapeutics Sales Price Analysis
5.4.4 Southeast Asia 2016 Gastrointestinal Therapeutics Market Share Analysis
5.5 Japan Gastrointestinal Therapeutics Market Analysis
5.5.1 Japan Gastrointestinal Therapeutics Market Overview
5.5.2 Japan 2012-2017E Gastrointestinal Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2012-2017E Gastrointestinal Therapeutics Sales Price Analysis
5.5.4 Japan 2016 Gastrointestinal Therapeutics Market Share Analysis
5.6 India Gastrointestinal Therapeutics Market Analysis
5.6.1 India Gastrointestinal Therapeutics Market Overview
5.6.2 India 2012-2017E Gastrointestinal Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2012-2017E Gastrointestinal Therapeutics Sales Price Analysis
5.6.4 India 2016 Gastrointestinal Therapeutics Market Share Analysis
6 Global 2012-2017E Gastrointestinal Therapeutics Segment Market Analysis (by Type)
6.1 Global 2012-2017E Gastrointestinal Therapeutics Sales by Type
6.2 Different Types of Gastrointestinal Therapeutics Product Interview Price Analysis
6.3 Different Types of Gastrointestinal Therapeutics Product Driving Factors Analysis
6.3.1 Tablets of Gastrointestinal Therapeutics Growth Driving Factor Analysis
6.3.2 Injection of Gastrointestinal Therapeutics Growth Driving Factor Analysis
7 Global 2012-2017E Gastrointestinal Therapeutics Segment Market Analysis (by Application)
7.1 Global 2012-2017E Gastrointestinal Therapeutics Consumption by Application
7.2 Different Application of Gastrointestinal Therapeutics Product Interview Price Analysis
7.3 Different Application of Gastrointestinal Therapeutics Product Driving Factors Analysis
7.3.1 IBD of Gastrointestinal Therapeutics Growth Driving Factor Analysis
7.3.2 Irritable Bowel Syndrome (IBS) of Gastrointestinal Therapeutics Growth Driving Factor Analysis
7.3.3 Other of Gastrointestinal Therapeutics Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Gastrointestinal Therapeutics
8.1 Johnson & Johnson
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Johnson & Johnson 2016 Gastrointestinal Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Johnson & Johnson 2016 Gastrointestinal Therapeutics Business Region Distribution Analysis
8.2 AbbVie
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 AbbVie 2016 Gastrointestinal Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 AbbVie 2016 Gastrointestinal Therapeutics Business Region Distribution Analysis
8.3 Allergan
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Allergan 2016 Gastrointestinal Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Allergan 2016 Gastrointestinal Therapeutics Business Region Distribution Analysis
8.4 Takeda
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Takeda 2016 Gastrointestinal Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Takeda 2016 Gastrointestinal Therapeutics Business Region Distribution Analysis
8.5 Novartis
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Novartis 2016 Gastrointestinal Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Novartis 2016 Gastrointestinal Therapeutics Business Region Distribution Analysis
8.6 Pfizer
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Pfizer 2016 Gastrointestinal Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Pfizer 2016 Gastrointestinal Therapeutics Business Region Distribution Analysis
8.7 GlaxoSmithKline
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 GlaxoSmithKline 2016 Gastrointestinal Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 GlaxoSmithKline 2016 Gastrointestinal Therapeutics Business Region Distribution Analysis
8.8 Merck
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Merck 2016 Gastrointestinal Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Merck 2016 Gastrointestinal Therapeutics Business Region Distribution Analysis
8.9 UCB (Belgium)
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 UCB (Belgium) 2016 Gastrointestinal Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 UCB (Belgium) 2016 Gastrointestinal Therapeutics Business Region Distribution Analysis
8.10 F. Hoffmann-La Roche
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 F. Hoffmann-La Roche 2016 Gastrointestinal Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 F. Hoffmann-La Roche 2016 Gastrointestinal Therapeutics Business Region Distribution Analysis
8.11 Eli Lilly
8.12 AstraZeneca
8.13 Procter & Gamble
8.14 Eisai
8.15 Shire Pharmaceuticals
8.16 Ferring Pharmaceuticals
8.17 Kyowa Hakko Kirin
8.18 Salix Pharmaceuticals
8.19 Ono Pharmaceutical
8.20 TSD Japan
8.21 RedHill Biopharma
8.22 Kaken Pharmaceutical
8.23 Amgen
8.24 Synergy Pharmaceuticals
8.25 Ajinomoto
8.26 Kissei Pharmaceutical
8.27 Hutchison Medi Pharma
9 Development Trend of Analysis of Gastrointestinal Therapeutics Market
9.1 Global Gastrointestinal Therapeutics Market Trend Analysis
9.1.1 Global 2017-2022 Gastrointestinal Therapeutics Market Size (Volume and Value) Forecast
9.1.2 Global 2017-2022 Gastrointestinal Therapeutics Sales Price Forecast
9.2 Gastrointestinal Therapeutics Regional Market Trend
9.2.1 North America 2017-2022 Gastrointestinal Therapeutics Consumption Forecast
9.2.2 China 2017-2022 Gastrointestinal Therapeutics Consumption Forecast
9.2.3 Europe 2017-2022 Gastrointestinal Therapeutics Consumption Forecast
9.2.4 Southeast Asia 2017-2022 Gastrointestinal Therapeutics Consumption Forecast
9.2.5 Japan 2017-2022 Gastrointestinal Therapeutics Consumption Forecast
9.2.6 India 2017-2022 Gastrointestinal Therapeutics Consumption Forecast
9.3 Gastrointestinal Therapeutics Market Trend (Product Type)
9.4 Gastrointestinal Therapeutics Market Trend (Application)
10 Gastrointestinal Therapeutics Marketing Type Analysis
10.1 Gastrointestinal Therapeutics Regional Marketing Type Analysis
10.2 Gastrointestinal Therapeutics International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Gastrointestinal Therapeutics by Region
10.4 Gastrointestinal Therapeutics Supply Chain Analysis
11 Consumers Analysis of Gastrointestinal Therapeutics
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 Conclusion of the Global Gastrointestinal Therapeutics Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Gastrointestinal Therapeutics
Table Product Specifications of Gastrointestinal Therapeutics
Table Classification of Gastrointestinal Therapeutics
Figure Global Production Market Share of Gastrointestinal Therapeutics by Type in 2016
Figure Tablets Picture
Table Major Manufacturers of Tablets
Figure Injection Picture
Table Major Manufacturers of Injection
Table Applications of Gastrointestinal Therapeutics
Figure Global Consumption Volume Market Share of Gastrointestinal Therapeutics by Application in 2016
Figure IBD Examples
Table Major Consumers in IBD
Figure Irritable Bowel Syndrome (IBS) Examples
Table Major Consumers in Irritable Bowel Syndrome (IBS)
Figure Other Examples
Table Major Consumers in Other
Figure Market Share of Gastrointestinal Therapeutics by Regions
Figure North America Gastrointestinal Therapeutics Market Size (Million USD) (2012-2022)
Figure China Gastrointestinal Therapeutics Market Size (Million USD) (2012-2022)
Figure Europe Gastrointestinal Therapeutics Market Size (Million USD) (2012-2022)
Figure Southeast Asia Gastrointestinal Therapeutics Market Size (Million USD) (2012-2022)
Figure Japan Gastrointestinal Therapeutics Market Size (Million USD) (2012-2022)
Figure India Gastrointestinal Therapeutics Market Size (Million USD) (2012-2022)
Table Gastrointestinal Therapeutics Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Gastrointestinal Therapeutics in 2016
Figure Manufacturing Process Analysis of Gastrointestinal Therapeutics
Figure Industry Chain Structure of Gastrointestinal Therapeutics
Table Capacity and Commercial Production Date of Global Gastrointestinal Therapeutics Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Gastrointestinal Therapeutics Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Gastrointestinal Therapeutics Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Gastrointestinal Therapeutics Major Manufacturers in 2016
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Gastrointestinal Therapeutics 2012-2017
Figure Global 2012-2017E Gastrointestinal Therapeutics Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Gastrointestinal Therapeutics Market Size (Value) and Growth Rate
Table 2012-2017E Global Gastrointestinal Therapeutics Capacity and Growth Rate
Table 2016 Global Gastrointestinal Therapeutics Capacity (K Pcs) List (Company Segment)
Table 2012-2017E Global Gastrointestinal Therapeutics Sales (K Pcs) and Growth Rate
Table 2016 Global Gastrointestinal Therapeutics Sales (K Pcs) List (Company Segment)
Table 2012-2017E Global Gastrointestinal Therapeutics Sales Price (USD/Pcs)
Table 2016 Global Gastrointestinal Therapeutics Sales Price (USD/Pcs) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Pcs) of Gastrointestinal Therapeutics 2012-2017E
Figure North America 2012-2017E Gastrointestinal Therapeutics Sales Price (USD/Pcs)
Figure North America 2016 Gastrointestinal Therapeutics Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Pcs) of Gastrointestinal Therapeutics 2012-2017E
Figure China 2012-2017E Gastrointestinal Therapeutics Sales Price (USD/Pcs)
Figure China 2016 Gastrointestinal Therapeutics Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Pcs) of Gastrointestinal Therapeutics 2012-2017E
Figure Europe 2012-2017E Gastrointestinal Therapeutics Sales Price (USD/Pcs)
Figure Europe 2016 Gastrointestinal Therapeutics Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Gastrointestinal Therapeutics 2012-2017E
Figure Southeast Asia 2012-2017E Gastrointestinal Therapeutics Sales Price (USD/Pcs)
Figure Southeast Asia 2016 Gastrointestinal Therapeutics Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Pcs) of Gastrointestinal Therapeutics 2012-2017E
Figure Japan 2012-2017E Gastrointestinal Therapeutics Sales Price (USD/Pcs)
Figure Japan 2016 Gastrointestinal Therapeutics Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Pcs) of Gastrointestinal Therapeutics 2012-2017E
Figure India 2012-2017E Gastrointestinal Therapeutics Sales Price (USD/Pcs)
Figure India 2016 Gastrointestinal Therapeutics Sales Market Share
Table Global 2012-2017E Gastrointestinal Therapeutics Sales (K Pcs) by Type
Table Different Types Gastrointestinal Therapeutics Product Interview Price
Table Global 2012-2017E Gastrointestinal Therapeutics Sales (K Pcs) by Application
Table Different Application Gastrointestinal Therapeutics Product Interview Price
Table Johnson & Johnson Information List
Table Product A Overview
Table Product B Overview
Table 2016 Johnson & Johnson Gastrointestinal Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Johnson & Johnson Gastrointestinal Therapeutics Business Region Distribution
Table AbbVie Information List
Table Product A Overview
Table Product B Overview
Table 2016 AbbVie Gastrointestinal Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 AbbVie Gastrointestinal Therapeutics Business Region Distribution
Table Allergan Information List
Table Product A Overview
Table Product B Overview
Table 2015 Allergan Gastrointestinal Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Allergan Gastrointestinal Therapeutics Business Region Distribution
Table Takeda Information List
Table Product A Overview
Table Product B Overview
Table 2016 Takeda Gastrointestinal Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Takeda Gastrointestinal Therapeutics Business Region Distribution
Table Novartis Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novartis Gastrointestinal Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Novartis Gastrointestinal Therapeutics Business Region Distribution
Table Pfizer Information List
Table Product A Overview
Table Product B Overview
Table 2016 Pfizer Gastrointestinal Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Pfizer Gastrointestinal Therapeutics Business Region Distribution
Table GlaxoSmithKline Information List
Table Product A Overview
Table Product B Overview
Table 2016 GlaxoSmithKline Gastrointestinal Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 GlaxoSmithKline Gastrointestinal Therapeutics Business Region Distribution
Table Merck Information List
Table Product A Overview
Table Product B Overview
Table 2016 Merck Gastrointestinal Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Merck Gastrointestinal Therapeutics Business Region Distribution
Table UCB (Belgium) Information List
Table Product A Overview
Table Product B Overview
Table 2016 UCB (Belgium) Gastrointestinal Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 UCB (Belgium) Gastrointestinal Therapeutics Business Region Distribution
Table F. Hoffmann-La Roche Information List
Table Product A Overview
Table Product B Overview
Table 2016 F. Hoffmann-La Roche Gastrointestinal Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 F. Hoffmann-La Roche Gastrointestinal Therapeutics Business Region Distribution
Table Eli Lilly Information List
Table AstraZeneca Information List
Table Procter & Gamble Information List
Table Eisai Information List
Table Shire Pharmaceuticals Information List
Table Ferring Pharmaceuticals Information List
Table Kyowa Hakko Kirin Information List
Table Salix Pharmaceuticals Information List
Table Ono Pharmaceutical Information List
Table TSD Japan Information List
Table RedHill Biopharma Information List
Table Kaken Pharmaceutical Information List
Table Amgen Information List
Table Synergy Pharmaceuticals Information List
Table Ajinomoto Information List
Table Kissei Pharmaceutical Information List
Table Hutchison Medi Pharma Information List
Figure Global 2017-2022 Gastrointestinal Therapeutics Market Size (K Pcs) and Growth Rate Forecast
Figure Global 2017-2022 Gastrointestinal Therapeutics Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Gastrointestinal Therapeutics Sales Price (USD/Pcs) Forecast
Figure North America 2017-2022 Gastrointestinal Therapeutics Consumption Volume (K Pcs) and Growth Rate Forecast
Figure China 2017-2022 Gastrointestinal Therapeutics Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Europe 2017-2022 Gastrointestinal Therapeutics Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Gastrointestinal Therapeutics Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Japan 2017-2022 Gastrointestinal Therapeutics Consumption Volume (K Pcs) and Growth Rate Forecast
Figure India 2017-2022 Gastrointestinal Therapeutics Consumption Volume (K Pcs) and Growth Rate Forecast
Table Global Sales Volume (K Pcs) of Gastrointestinal Therapeutics by Type 2017-2022
Table Global Consumption Volume (K Pcs) of Gastrointestinal Therapeutics by Application 2017-2022
Table Traders or Distributors with Contact Information of Gastrointestinal Therapeutics by Region
  • Global Calming and Sleeping Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 17-Oct-2018        Price: US 3480 Onwards        Pages: 132
    Calming and sleeping products reduce tension and anxiety by inducing sedatives and a hypnotic effect on the body. They act by depressing the central nervous system. Scope of the Report: This report focuses on the Calming and Sleeping in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. They are used to tr......
  • Global Glycinates Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 17-Oct-2018        Price: US 3480 Onwards        Pages: 137
    Glycine is an amino acid of endogenous antioxidant reductive glutathione. It is often added exogenously in severe stress, sometimes called semi-essential amino acid. Scope of the Report: This report focuses on the Glycinates in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The feed additive segment is ......
  • Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 35
    Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Pipeline Review, H2 2018 Summary Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Aurora Kinase C is a member of the Aurora sub......
  • Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Beta or PIK3CB or EC 2.7.1.153) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 74
    Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Beta or PIK3CB or EC 2.7.1.153) - Pipeline Review, H2 2018 Summary Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Beta or PIK3CB or EC 2.7.1.153) pipeline Target constitutes close to 15 molecules. Out of which app......
  • Transforming Growth Factor Beta 2 (BSC1 Cell Growth Inhibitor or Cetermin or Glioblastoma Derived T Cell Suppressor Factor or Polyergin or TGFB2) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 50
    Transforming Growth Factor Beta 2 (BSC1 Cell Growth Inhibitor or Cetermin or Glioblastoma Derived T Cell Suppressor Factor or Polyergin or TGFB2) - Pipeline Review, H2 2018 Summary Transforming Growth Factor Beta 2 (BSC1 Cell Growth Inhibitor or Cetermin or Glioblastoma Derived T Cell Suppressor Factor or Polyergin or TGFB2) - Transforming growth factor beta 2 (TGF-ß2) is a polypeptide member of the transforming growth factor beta superfamily of cytokines encoded by......
  • Transforming Growth Factor Beta 1 (TGFB1) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 73
    Transforming Growth Factor Beta 1 (TGFB1) - Pipeline Review, H2 2018 Summary Transforming Growth Factor Beta 1 (TGFB1) pipeline Target constitutes close to 22 molecules. Out of which approximately 15 molecules are developed by companies and remaining by the universities/institutes. The latest report Transforming Growth Factor Beta 1- Pipeline Review, H2 2018, outlays comprehensive information on the Transforming Growth Factor Beta 1 (TGFB1) targeted therapeutics, co......
  • Beta Secretase 1 (Aspartyl Protease 2 or Beta Site Amyloid Precursor Protein Cleaving Enzyme 1 or Memapsin 2 or Membrane Associated Aspartic Protease 2 or BACE1 or EC 3.4.23.46) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 69
    Beta Secretase 1 (Aspartyl Protease 2 or Beta Site Amyloid Precursor Protein Cleaving Enzyme 1 or Memapsin 2 or Membrane Associated Aspartic Protease 2 or BACE1 or EC 3.4.23.46) - Pipeline Review, H2 2018 Summary Beta Secretase 1 (Aspartyl Protease 2 or Beta Site Amyloid Precursor Protein Cleaving Enzyme 1 or Memapsin 2 or Membrane Associated Aspartic Protease 2 or BACE1 or EC 3.4.23.46) - Beta-secretase 1 (BACE1) is an enzyme that in humans is encoded by the BACE1 ......
  • Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 73
    Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Pipeline Review, H2 2018 Summary According to the recently published report 'Lysosomal Alpha Glucosidase - Pipeline Review, H2 2018'; Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) pipeline Target constitutes close to 16 molecules. Out of which approximately 13 molecules are developed by companies and remaining by the universities/institutes......
  • Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 56
    Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2018 Summary Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) pipeline Target constitutes close to 17 molecules. Out of which approximately 12 molecules are developed by companies and remaining by the universities/institutes. The latest report Glycogen Synthase Kinase 3 Be......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs